Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 10/2017

01-10-2017 | Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors)

The Effects of Chronic Aerobic Exercise on Cardiovascular Risk Factors in Persons with Diabetes Mellitus

Authors: Emily M. Miele, Samuel A. E. Headley

Published in: Current Diabetes Reports | Issue 10/2017

Login to get access

Abstract

Purpose of Review

Aerobic exercise training is a component of diabetes mellitus (DM) care guidelines due to its favorable effects on glycemic control and cardiovascular disease (CVD) risk factors. The purpose of this review is to outline the recent evidence regarding the clinical effects of chronic aerobic exercise on CVD risk factors in persons with DM and to compare the effects of varying intensities and types of exercise.

Recent Findings

Among individuals with DM, all types of aerobic exercise training can impact positively on some traditional and non-traditional risk factors for CVD. Training programs with a higher volume or intensity induce greater improvements in vascular function, cardiorespiratory fitness (CRF), and lipid profiles.

Summary

The beneficial outcomes of aerobic training include improvements in glycemic control, endothelial function, oxidative stress, dyslipidemia, myocardial function, adiposity, and CRF. Findings regarding markers of inflammation are discrepant and further research should focus on the role of exercise to impact upon the chronic inflammation associated with DM.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117(15):1945–54.CrossRefPubMed
4.
Association AD. American Diabetes Association standards of medical care in diabetes—2017. J Clin Appl Res Educ. 2017;40:1–142.
5.
Boulé NG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in type 2 diabetes mellitus. Diabetologia. 2003;46(8):1071–81.CrossRefPubMed
6.
ACSM. ACSM’s guidelines for exercise testing and prescription. 10th ed. Philadelphia, PA: Walters Kluwer; 2017. p. 268–275.
7.
• Mitranun W, Deerochanawong C, Tanaka H, Suksom D. Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients. Scand J Med Sci Sport. 2014;24(2):69–76. This study assessed a vast range of CVD risk factors in response to aerobic training in addition to comparing the effects of HIIT and MICT programs. CrossRef
8.
Church TS, Blair SN, Cocreham S, Johnson W, Kramer K, Mikus CR, et al. Effects of aerobic and resistance training on hemoglobin a1c levels in patients with type 2 diabetes. JAMA J Am Med Assoc. 2010;304(20):2253–62.CrossRef
9.
Sigal RJ, Kenny GP, Boule NG, Wells GA, Prud D, Fortier M, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes. Ann Intern Med. 2007;147(6):357–69.CrossRefPubMed
10.
De Lemos ET, Oliveira J, Pinheiro JP, Reis F. Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus. Oxidative Med Cell Longev. 2012;2012:1–15.
11.
Petrofsky JS. The effect of type-2-diabetes-related vascular endothelial dysfunction on skin physiology and activities of daily living. J Diabetes Sci Technol. 2011;5(3):657–67.CrossRefPubMedPubMedCentral
12.
Virdis A, Ghiadoni L, Giannarelli CTS. Endothelial dysfunction and vascular disease in later life. Maturitas. 2010;67(1):20–4.CrossRefPubMed
13.
Balducci S, Zanuso S, Nicolucci A, De Feo P, Cavallo S, Cardelli P, et al. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus. Arch Intern Med. 2010;170(20):1794–803.CrossRefPubMed
14.
Dadgostar H, Firouuzinezhad S, Ansari M, Younespour S, Mahmoudpour A, Khamseh ME. Supervised group-exercise therapy versus home-based exercise therapy: their effects on quality of life and cardiovascular risk factors in women with type 2 diabetes. Diabetes Metab Syndr Clin Res Rev. 2016;10:30–6.CrossRef
15.
Pandey A, Swift DL, McGuire DK, Ayers CR, Neeland IJ, Blair SN, et al. Metabolic effects of exercise training among fitness-nonresponsive patients with type 2 diabetes: the HART-D study. Diabetes Care. 2015;38(8):1494–501.CrossRefPubMedPubMedCentral
16.
Yardley JE, Hay J, Abou-Setta AM, Marks SD, McGavock J. A systematic review and meta-analysis of exercise interventions in adults with type 1 diabetes. Diabetes Res Clin Pract. 2014;106(3):393–400.CrossRefPubMed
17.
Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev. 2013;93(3):993–1017.CrossRefPubMed
18.
Dos Santos JM, Moreli ML, Tewari S, Benite-Ribeiro SA. The effect of exercise on skeletal muscle glucose uptake in type 2 diabetes: an epigenetic perspective. Metabolism. 2015;64(12):1619–28.CrossRefPubMed
19.
Hollekim-Strand SM, Bjørgaas MR, Albrektsen G, Tjønna AE, Wisløff U, Ingul CB. High-intensity interval exercise effectively improves cardiac function in patients with type 2 diabetes mellitus and diastolic dysfunction: a randomized controlled trial. J Am Coll Cardiol. 2014;64(16):1758–60.CrossRefPubMed
20.
Fuchsjäger-Mayrl G, Pleiner J, Wiesinger GF, Sieder AE, Quittan M, Nuhr MJ, et al. Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care. 2002;25(10):1795–801.CrossRefPubMed
21.
Ma RC. Genetics of cardiovascular and renal complications in diabetes. J Diabetes Investig. 2016;7(2):139–54.CrossRefPubMed
22.
He ZH, Eon SAD, Tinsley LJ, Fitzgerald S, Hastings SM, Khamaisi M, et al. Cardiovascular disease protection in long-duration type 1 diabetes and sex differences. Diabetes Care. 2015;38:73–4.CrossRef
23.
• De Moraes R, Bavel DV, Gomes MD, Tibirica E. Effects of non-supervised low intensity aerobic excise training on the microvascular endothelial function of patients with type 1 diabetes: a non-pharmacological interventional study. BMC Cardiovasc Disord. 2016;16(1):23. This is one of very few recent original research with T1DM subjects utilizing an aerobic exercise training protocol. It involved the assessment of vascular function and tissue perfusion. CrossRefPubMedPubMedCentral
24.
Kasumov T, Solomon TPJ, Hwang C, Huang H, Haus JM, Zhang R, et al. Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes. Obesity. 2015;23(7):1414–21.CrossRefPubMedPubMedCentral
25.
Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA, et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes. 2009;58(2):337–43.CrossRefPubMedPubMedCentral
26.
Revdal A, Hollekim-strand SM, Ingul CB. Can time efficient exercise improve cardiometabolic risk factors in type 2 diabetes? A pilot study. J Sport Sci Med. 2016;15(2):308–13.
27.
Myers J, Tan SY, Abella J, Aleti VFV. Comparison of the chronotropic response to exercise and heart rate recovery in predicting cardiovascular mortality. Eur J Cardiovasc Prev Rehabil. 2007;14(2):215–21.CrossRefPubMed
28.
Herder C, Illig T, Rathmann W, Martin S, Haastert B, Müller-Scholze S, et al. Inflammation and type 2 diabetes: results from KORA Augsburg. Das Gesundheitswes. 2005;67(S 01):115–21.CrossRef
29.
Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98–107.CrossRefPubMed
30.
31.
Karstoft K, Pedersen BK. Exercise and type 2 diabetes: focus on metabolism and inflammation. Immunol Cell Biol. 2016;94(2):146–50.CrossRefPubMed
32.
Kadoglou NPE, Fotiadis G, Kapelouzou A, Kostakis A, Liapis CD, Vrabas IS. The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with type 2 diabetes. Diabet Med. 2013;30(2):41–51.CrossRef
33.
Hayashino Y, Jackson JL, Hirata T, Fukumori N, Nakamura F, Fukuhara S, et al. Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Metabolism. 2014;63(3):431–40.CrossRefPubMed
34.
Mallard AR, Hollekim-Strand SM, Coombes JS, Ingul CB. Exercise intensity, redox homeostasis and inflammation in type 2 diabetes mellitus. J Sci Med Sport. 2017; 20:893–898.CrossRefPubMed
35.
Krause M, Rodrigues-Krause J, O’Hagan C, Medlow P, Davison G, Susta D, et al. The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production. Eur J Appl Physiol. 2014;114(2):251–60.CrossRefPubMed
36.
Melo LC, Dativo-Medeiros J, Menezes-Silva CE, Barbosa FT, de Sousa-Rodrigues CF, Rabelo LA. Physical exercise on inflammatory markers in type 2 diabetes patients: a systematic review of randomized controlled trials. Oxidative Med Cell Longev. 2017;2017:8523728.CrossRef
37.
Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JPH, Pinkney JH. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J. 2006;82(966):280–4.CrossRefPubMedPubMedCentral
38.
Keane KN, Cruzat VF, Carlessi R, Ivo P, De Bittencourt H, Newsholme P. Molecular events linking oxidative stress and inflammation to insulin resistance and B-cell dysfunction. 2015;2015.
39.
Yavari A, Najafipoor F, Aliasgarzadeh A, Niafar M, Mobasseri M. Effect of aerobic exercise, resistance training or combined training on glycaemic control and cardio-vascular risk factors in patients with type 2 diabetes. Biol Sport. 2012;29(2):135–43.CrossRef
40.
Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth KG, Taylor R, et al. High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2016;59(1):56–66.CrossRefPubMed
41.
Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, et al. The effects of free-living interval- walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients. Diabetes Care. 2013;36:228–36.CrossRefPubMedPubMedCentral
42.
Shakil-ur-Rehman S, Karimi H, Gillani SA. Effects of supervised structured aerobic exercise training program on high and low density lipoprotein in patients with type II diabetes mellitus. Pak J Med Sci. 2017;33(1):96–9.CrossRefPubMedPubMedCentral
43.
Hayashino Y, Jackson JL, Fukumori N, Nakamura F, Fukuhara S. Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2012;98:349–60.CrossRefPubMed
44.
Sixt S, Beer S, Blüher M, Korff N, Peschel T, Sonnabend M, et al. Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. Eur Heart J. 2010;31(1):112–9.CrossRefPubMed
45.
Laaksonen DE, Atalay M, Niskanen LK, Mustonen J, Sen CK, Lakka TA, et al. Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial. Med Sci Sports Exerc. 2000;32(9):1541–8.CrossRefPubMed
46.
Nuhu JM, Maharaj SS. Influence of a mini trampoline rebound exercise program on insulin resistance, lipid profile and central obesity in individuals with type 2 diabetes. J Sports Med Phys Fitness. 2017. doi:10.​23736/​S0022-4707.​17.​07120-1.
47.
Wilson LC, Peebles KC, Hoye NA, Manning P, Sheat C, Williams MJA, et al. Resting heart rate variability and exercise capacity in type 1 diabetes. Physiol Rep. 2017;5(8):e13248.CrossRefPubMedPubMedCentral
48.
Turinese I, Marinelli P, Bonini M, Rossetti M, Statuto G, Filardi T, et al. Metabolic and cardiovascular response to exercise in patients with type 1 diabetes. J Endocrinol Invest. 2017;40(9):999–1005.CrossRef
49.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood A. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801.CrossRefPubMed
50.
Schreuder THA, Maessen MFH, Tack CJ, Thijssen DHJ, Hopman MTE. Life-long physical activity restores metabolic and cardiovascular function in type 2 diabetes. Eur J Appl Physiol. 2014;114(3):619–27.CrossRefPubMed
51.
Johannsen NM, Swift DL, Lavie CJ, Earnest CP, Blair SN, Timothy SC. Categorical analysis of the impact of aerobic and resistance exercise training, alone and in combination, on cardiorespiratory fitness levels in patients with type 2 diabetes. Diabetes Care. 2013;36:3305–12.CrossRefPubMedPubMedCentral
52.
Cooper AJM, Brage S, Ekelund U, Wareham NJ, Griffin SJ, Simmons RK. Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia. 2014;57(1):73–82.CrossRefPubMed
53.
Umpierre D, Kramer CK, Leita CB, Gross JL, Ribeiro JP, Schaan BD. Physical activity advice only or structured exercise training and association with HbA 1c levels in type 2 diabetes. JAMA J Am Med Assoc. 2011;305:1790–9.CrossRef
Metadata
Title
The Effects of Chronic Aerobic Exercise on Cardiovascular Risk Factors in Persons with Diabetes Mellitus
Authors
Emily M. Miele
Samuel A. E. Headley
Publication date
01-10-2017
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 10/2017
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0927-7

Other articles of this Issue 10/2017

Current Diabetes Reports 10/2017 Go to the issue

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Animal Models of Diabetic Retinopathy

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Intraocular Inflammation in Diabetic Populations

Diabetes and Pregnancy (M-F Hivert, Section Editor)

Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and Outcomes

Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)

Tolerogenic Nanoparticles to Treat Islet Autoimmunity

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Screening Intervals for Diabetic Retinopathy and Implications for Care

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Cardiovascular and Mortality Risks in Migrant South Asians with Type 2 Diabetes: Are We Winning the Battle?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits